Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with prostate cancer for at least one year
- People who currently do less than 150 minutes of physical activity per week (which the World Health Organization considers inactive)
- People who are covered by a social security or health insurance scheme
- People who have been fully informed about the study and have signed a consent form together with the trial investigator
Who may not be able to join:
- People who are currently receiving cancer treatment, other than hormone therapy
- People who have significant health conditions that make physical activity unsafe, such as heart conditions, breathing conditions, or severe joint problems that limit movement
- People who are under legal guardianship or are not free to make their own decisions (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David HUPIN, MD PhD, CHU de Saint-Etienne
Phone: (0)477828413
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective measurement of physical activity (in MET-hr/week, Metabolic Equivalent of Task (MET), measures the intensity of physical activity)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.